4//SEC Filing
Kim Jong Joseph 4
Accession 0001055726-22-000020
CIK 0001055726other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:36 PM ET
Size
12.4 KB
Accession
0001055726-22-000020
Insider Transaction Report
Form 4
Kim Jong Joseph
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2022-03-11+139,387→ 1,462,325 total - Tax Payment
Common Stock
2022-03-11$3.22/sh−39,698$127,828→ 1,422,627 total - Exercise/Conversion
Restricted Stock Unit
2022-03-11−139,387→ 139,386 total→ Common Stock (139,387 underlying)
Holdings
- 33,533(indirect: By Son: JK2)
Common Stock
- 816,527(indirect: By Partnership)
Common Stock
- 33,563(indirect: By Daughter: EK)
Common Stock
- 33,775(indirect: By Son: JK1)
Common Stock
- 5,975(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001464549
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:36 PM ET
- Size
- 12.4 KB